# Changchun GeneScience Pharmaceutical Co., Ltd. — FDA import alert red lists: firms subject to detention without physical examination

For Changchun GeneScience Pharmaceutical Co., Ltd., firm is Changchun GeneScience Pharmaceutical Co., Ltd; import alert is 66-57; import alert name is "Detention Without Physical Examination of Foreign Manufactured Unapproved Prescription Drugs Distributed to Individuals in the U.S."; country is CHINA; address is No. 72 Tianhe Street , Changchun High-Tech Dev. Zone , Changchun City, Jilin CHINA, verified against its source on 2026-08-06.

- **Firm:** Changchun GeneScience Pharmaceutical Co., Ltd. _(verified: appears in the quote below)_
- **Import alert:** 66-57 _(verified: appears in the quote below)_
- **Import alert name:** "Detention Without Physical Examination of Foreign Manufactured Unapproved Prescription Drugs Distributed to Individuals in the U.S." _(verified: appears in the quote below)_
- **Country:** CHINA _(verified: appears in the quote below)_
- **Address:** No. 72 Tianhe Street , Changchun High-Tech Dev. Zone , Changchun City, Jilin CHINA _(verified: appears in the quote below)_
- **Date published:** 09/10/2009 _(verified: appears in the quote below)_
- **Product code:** 64 R C P 18 Human Growth Hormone (Hormone), Human - Rx/Single Ingredient, Small Volume Parenteral _(verified: appears in the quote below)_
- **Product:** GenLei Jintropin Someatropin rDNA origin human growth hormone _(verified: appears in the quote below)_
- **FDA notes:** 9/4/2003 _(verified: appears in the quote below)_

## What the source says

> Changchun GeneScience Pharmaceutical Co., Ltd. Date Published : 09/10/2009 No. 72 Tianhe Street , Changchun High-Tech Dev. Zone , Changchun City, Jilin CHINA 64 R C P 18 Human Growth Hormone (Hormone), Human - Rx/Single Ingredient, Small Volume Parenteral Date Published: 02/18/2021 Desc: GenLei Jintropin Someatropin rDNA origin human growth hormone Notes: 9/4/2003

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_197.html

Last verified: 2026-08-06. Review by: 2026-10-05.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).